(Q43760972)

26 November 2017

The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study (English)

1 reference

26 November 2017

myocardial infarction

1 reference

1

1 reference

26 November 2017

H Lee

2

1 reference

PubMed ID

21777216

26 November 2017

A B Kimball

series ordinal

3

1 reference

PubMed ID

21777216

26 November 2017

language of work or name

English

0 references

publication date

1 November 2011

1 reference

British Journal of Dermatology

26 November 2017

1 reference

26 November 2017

165

1 reference

26 November 2017

5

1 reference

26 November 2017

1066-1073

1 reference

Psoriasis and metabolic disease: epidemiology and pathophysiology

26 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Cytokine milieu in psoriasis and cardiovascular disease may explain the epidemiological findings relating these 2 diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

The risk of stroke in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Heart disease in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

AJC editor's consensus: psoriasis and coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Cytokines and anticytokines in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

The inflammatory response in mild and in severe psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Psoriasis and vascular disease: an unsolved mystery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: A double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

National Psoriasis Foundation clinical consensus on disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Decision points for the initiation of systemic treatment for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

The effect of chronic ultraviolet radiation on the human immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

The burden of illness associated with psoriasis: cost of treatment with systemic therapy and phototherapy in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

National registries of systemic treatment for psoriasis and the European 'Psonet' initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Role of Inflammation in Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

Cytokine profiles during infliximab monotherapy in psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10525.X

10.1111/J.1365-2133.2011.10525.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference

PubMed ID

21777216